High-Resolution Whole-Body Magnetic Resonance Image Tumor Staging With the Use of Parallel Imaging Versus Dual-Modality Positron Emission Tomography–Computed Tomography: Experience on a 32-Channel System
暂无分享,去创建一个
S. Schoenberg | M. Reiser | G. Schmidt | A. Baur-Melnyk | R. Tiling | P. Herzog | R. Schmid | Michaela Schmidt | M. Schmidt | A. Baur‐Melnyk | S. Schönberg
[1] T. Nägele,et al. Fast Whole-Body Assessment of Metastatic Disease Using a Novel Magnetic Resonance Imaging System: Initial Experiences , 2005, Investigative radiology.
[2] L. Bonomo,et al. Accuracy of computed tomography and magnetic resonance imaging in staging bronchogenic carcinoma , 1996, Magnetic Resonance Materials in Physics, Biology and Medicine.
[3] R. Hustinx,et al. Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography , 1996, European Journal of Nuclear Medicine.
[4] S. Schoenberg,et al. High‐resolution MR‐imaging of the liver with T2‐weighted sequences using integrated parallel imaging: Comparison of prospective motion correction and respiratory triggering , 2004, Journal of magnetic resonance imaging : JMRI.
[5] E. Moser,et al. Ganzkörper-MRT vs. Skelettszintigraphie bei der Detektion ossärer Metastasen solider Tumoren , 2004, Der Radiologe.
[6] J. Debatin,et al. HASTE MRI versus chest radiography in the detection of pulmonary nodules: comparison with MDCT. , 2004, AJR. American journal of roentgenology.
[7] V. Bettinardi,et al. Value of integrated PET/CT for lesion localisation in cancer patients: a comparative study , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[8] M. Langer,et al. [Whole-body MRI in comparison to skeletal scintigraphy for detection of skeletal metastases in patients with solid tumors]. , 2004, Der Radiologe.
[9] Thomas Beyer,et al. FDG-PET/CT in re-staging of patients with lymphoma , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[10] J. Debatin,et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. , 2003, JAMA.
[11] R. Wahl,et al. Direct Comparison of 18F-FDG PET and PET/CT in Patients with Colorectal Carcinoma , 2003 .
[12] Mithat Gonen,et al. Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] M. Kanematsu,et al. Spectrum of MRI appearances of untreated metastases of the liver. , 2003, AJR. American journal of roentgenology.
[14] G. V. von Schulthess,et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. , 2003, The New England journal of medicine.
[15] Hans-Jürgen Gallowitsch,et al. F-18 Fluorodeoxyglucose Positron-Emission Tomography in the Diagnosis of Tumor Recurrence and Metastases in the Follow-Up of Patients With Breast Carcinoma: A Comparison to Conventional Imaging , 2003, Investigative radiology.
[16] Yuji Nakamoto,et al. Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[17] P M Jakob,et al. Resolution enhancement in lung 1H imaging using parallel imaging methods , 2003, Magnetic resonance in medicine.
[18] S. Eustace,et al. Current concepts in whole-body imaging using turbo short tau inversion recovery MR imaging. , 2003, AJR. American journal of roentgenology.
[19] Robin M Heidemann,et al. Generalized autocalibrating partially parallel acquisitions (GRAPPA) , 2002, Magnetic resonance in medicine.
[20] Stephen J Riederer,et al. Continuously moving table data acquisition method for long FOV contrast‐enhanced MRA and whole‐body MRI , 2002, Magnetic resonance in medicine.
[21] O. Hoekstra,et al. Systematic review of the diagnostic accuracy of 18F‐fluorodeoxyglucose positron emission tomography in melanoma patients , 2001 .
[22] R. Semelka,et al. Focal liver lesions: Comparison of dual‐phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement , 2001, Journal of magnetic resonance imaging : JMRI.
[23] A. Gandjour,et al. Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results , 2000, European Journal of Nuclear Medicine.
[24] Paul Kinahan,et al. A combined PET/CT scanner for clinical oncology. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[25] H. Groen,et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. , 2000, The New England journal of medicine.
[26] H. Curtin,et al. Imaging-based nodal classification for evaluation of neck metastatic adenopathy. , 2000, AJR. American journal of roentgenology.
[27] P. Boesiger,et al. SENSE: Sensitivity encoding for fast MRI , 1999, Magnetic resonance in medicine.
[28] R. Edelman,et al. Resolution enhancement in single‐shot imaging using simultaneous acquisition of spatial harmonics (SMASH) , 1999, Magnetic resonance in medicine.
[29] M. Reiser,et al. Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system. , 1999, Journal of computer assisted tomography.
[30] D. Vanel,et al. MRI of bone metastases , 1998, European Radiology.
[31] R. Semelka,et al. Liver lesion detection, characterization, and effect on patient management: Comparison of single‐phase spiral CT and current MR techniques , 1997, Journal of magnetic resonance imaging : JMRI.
[32] P. Valk,et al. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. , 1995, The Annals of thoracic surgery.
[33] A. Zauber,et al. Preoperative staging of gastric cancer: comparison of endoscopic US and dynamic CT. , 1991, Radiology.
[34] B. Gross,et al. Upper abdominal lymph nodes: criteria for normal size determined with CT. , 1991, Radiology.
[35] W. Chilcote,et al. Abdominal lymphadenopathy: spectrum of CT findings. , 1991, Radiographics : a review publication of the Radiological Society of North America, Inc.
[36] P. Roemer,et al. The NMR phased array , 1990, Magnetic resonance in medicine.
[37] F L Bookstein,et al. Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. , 1985, AJR. American journal of roentgenology.
[38] W. Youden,et al. Index for rating diagnostic tests , 1950, Cancer.